Literature DB >> 19933421

Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts.

Jason D Gardner1, David B Murray, Tetyana G Voloshenyuk, Gregory L Brower, Jessica M Bradley, Joseph S Janicki.   

Abstract

We have previously reported gender differences in ventricular remodeling and development of heart failure using the aortocaval fistula model of chronic volume overload in rats. In contrast to males, female rats exhibited no adverse ventricular remodeling and less mortality in response to volume overload. This gender-specific cardioprotection was lost following ovariectomy and was partially restored using estrogen replacement. However, it is not known if estrogen treatment would be as effective in males. The purpose of this study was to evaluate the structural and functional effects of estrogen in male rats subjected to chronic volume overload. Four groups of male rats were studied at 3 days and 8 wk postsurgery as follows: fistula and sham-operated controls, with and without estrogen treatment. Biochemical and histological studies were performed at 3 days postsurgery, with chronic structural and functional effects studied at 8 wk. Measurement of systolic and diastolic pressure-volume relationships was obtained using a blood-perfused isolated heart preparation. Both fistula groups developed significant ventricular hypertrophy after 8 wk of volume overload. Untreated rats with fistula exhibited extensive ventricular dilatation, which was coupled with a loss of systolic function. Estrogen attenuated left ventricular dilatation and maintained function in treated rats. Estrogen treatment was also associated with a reduction in oxidative stress and circulating endothelin-1 levels, as well as prevention of matrix metalloproteinase-2 and -9 activation and breakdown of ventricular collagen in the early stage of remodeling. These data demonstrate that estrogen attenuates ventricular remodeling and disease progression in male rats subjected to chronic volume overload.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933421      PMCID: PMC2822568          DOI: 10.1152/ajpheart.00336.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  47 in total

Review 1.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 2.  Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation.

Authors:  J W Coleman
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

3.  Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling.

Authors:  K S Russell; M P Haynes; D Sinha; E Clerisme; J R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats.

Authors:  N Sudoh; K Toba; M Akishita; J Ako; M Hashimoto; K Iijima; S Kim; Y Q Liang; Y Ohike; T Watanabe; I Yamazaki; M Yoshizumi; M Eto; Y Ouchi
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

5.  TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.

Authors:  Lynetta J Jobe; Giselle C Meléndez; Scott P Levick; Yan Du; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

6.  Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression.

Authors:  J Zhou; S Ng; O Adesanya-Famuiya; K Anderson; C A Bondy
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

7.  17beta-estradiol attenuates the development of pressure-overload hypertrophy.

Authors:  M van Eickels; C Grohé; J P Cleutjens; B J Janssen; H J Wellens; P A Doevendans
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

8.  Gender differences in cardiac remodeling secondary to chronic volume overload.

Authors:  Jason D Gardner; Gregory L Brower; Joseph S Janicki
Journal:  J Card Fail       Date:  2002-04       Impact factor: 5.712

9.  A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Authors:  F G Spinale; M L Coker; L J Heung; B R Bond; H R Gunasinghe; T Etoh; A T Goldberg; J L Zellner; A J Crumbley
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

10.  Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity.

Authors:  Gregory L Brower; Amanda L Chancey; Srihari Thanigaraj; Beatriz B Matsubara; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

View more
  36 in total

1.  Estrogenic modulation of inflammation-related genes in male rats following volume overload.

Authors:  Jennifer L McLarty; Giselle C Meléndez; Scott P Levick; Shanté Bennett; Tara Sabo-Attwood; Gregory L Brower; Joseph S Janicki
Journal:  Physiol Genomics       Date:  2012-01-24       Impact factor: 3.107

2.  Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.

Authors:  Kristin Wilson; Anuradha Guggilam; T Aaron West; Xiaojin Zhang; Aaron J Trask; Mary J Cismowski; Pieter de Tombe; Sakthivel Sadayappan; Pamela A Lucchesi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

Review 3.  Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review.

Authors:  Vitaris Kodogo; Feriel Azibani; Karen Sliwa
Journal:  Clin Res Cardiol       Date:  2019-02-26       Impact factor: 5.460

4.  Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

Authors:  Jianping Li; Shaiban Jubair; Joseph S Janicki
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

5.  Regular exercise modulates cardiac mast cell activation in ovariectomized rats.

Authors:  Sukanya Phungphong; Anusak Kijtawornrat; Jonggonnee Wattanapermpool; Tepmanas Bupha-Intr
Journal:  J Physiol Sci       Date:  2015-10-14       Impact factor: 2.781

Review 6.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 7.  Estrogen, hormonal replacement therapy and cardiovascular disease.

Authors:  Xiao-Ping Yang; Jane F Reckelhoff
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

Review 8.  Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase.

Authors:  Joseph S Janicki; Francis G Spinale; Scott P Levick
Journal:  Pflugers Arch       Date:  2013-02-16       Impact factor: 3.657

9.  New frontiers in heart hypertrophy during pregnancy.

Authors:  Jingyuan Li; Soban Umar; Marjan Amjedi; Andrea Iorga; Salil Sharma; Rangarajan D Nadadur; Vera Regitz-Zagrosek; Mansoureh Eghbali
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

Review 10.  Membrane-associated matrix proteolysis and heart failure.

Authors:  Francis G Spinale; Joseph S Janicki; Michael R Zile
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.